U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445217) titled 'Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia' on Feb. 25.
Brief Summary: The Positive and Negative Syndrome Scale (PANSS) is a widely used instrument for assessing symptom severity in schizophrenia, whereas the Personal and Social Performance Scale (PSP) provides a practical measure of functional outcomes. This study aimed to evaluate the predictive validity of the PSP for PANSS outcomes in individuals with schizophrenia.
A total of 763 patients diagnosed with schizophrenia and receiving paliperidone treatment were recruited in a 12-week multicenter prospective study. Among pa...